Bone marrow stem cell as a potential treatment for diabetes

Area of Science:

• Regenerative Medicine
• Endocrinology
• Stem Cell Biology

Background:

• Diabetes mellitus (DM) is characterized by hyperglycemia due to impaired insulin secretion or action.
• Chronic high blood glucose damages vital organs including eyes, kidneys, nerves, heart, and blood vessels.
• Current therapies like diet, insulin, and oral agents often fail to achieve sustained normal glucose levels.

Purpose of the Study:

• To review the potential of stem cells for generating functional beta cells for diabetes treatment.
• To focus specifically on the application of bone marrow stem cells (BMSCs) for type 1 and type 2 DM.

Main Methods:

• Review of current research on stem cell-based therapies for diabetes.
• Classification of stem cells into embryonic stem cells (ESCs) and tissue stem cells (TSCs).
• Focus on bone marrow-, liver-, and pancreas-derived stem cells within the TSC category.

Main Results:

• Stem cells, including ESCs and TSCs, are being investigated for their ability to generate functional beta cells.
• Bone marrow stem cells are identified as a key focus for treating both type 1 and type 2 diabetes.
• Limitations of current therapies and organ transplantation highlight the need for alternative solutions.

Conclusions:

• Stem cell therapy, particularly using bone marrow stem cells, presents a promising alternative for managing diabetes mellitus.
• Further research into generating functional beta cells from stem cells is crucial for overcoming donor organ shortages.
• This approach holds potential for improved glucose control in patients with type 1 and type 2 DM.